[Inhibition of in vitro polyclonal antibody synthesis in systemic lupus erythematosus by a soluble suppressor factor].
D000917:Antibody Formation / Q000187:drug effects*; D002478:Cells, Cultured; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008222:Lymphokines / Q000494:pharmacology*; D013154:Spleen / Q000473:pathology; D013491:Suppressor Factors, Immunologic; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D008222:Lymphokines; D013491:Suppressor Factors, Immunologic; C013256:soluble immune response suppressor